CD44, IL8, CXCR2 and c-myc were consistently overexpressed in CRC patients; hence, we further investigated their levels among healthy control, polyp and CRC patients and evaluated their potential as screening biomarkers in the validation study. The gene discussed is CD44; the disease is colorectal carcinoma.